Melanoma tumor cell heterogeneity: A molecular approach to study subpopulations expressing the embryonic morphogen nodal

Seminars in Oncology

Volumn 41, Issue 2, 2014, Pages 259-266

  Seftor, Elisabeth A ^a   Seftor, Richard E B ^a   Weldon, Don S ^b   Kirsammer, Gina T ^a   Margaryan, Naira V ^a   Gilgur, Alina ^a   Hendrix, Mary J C ^a  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b MILLIPORE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MORPHOGEN; NODAL SIGNALING PROTEIN;

APOPTOSIS; ARTICLE; BIOASSAY; CANCER PATIENT; CANCER PROGNOSIS; CANCER STEM CELL; CELL DIFFERENTIATION; CELL GROWTH; CELL HETEROGENEITY; CELL RENEWAL; CELL SUBPOPULATION; EMBRYONIC STEM CELL; GROWTH CURVE; HUMAN; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MELANOMA; MELANOMA CELL; METASTATIC MELANOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VERTICAL GROWTH PHASE; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL SEPARATION; CYTOLOGICAL TECHNIQUES; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC TECHNIQUES; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; MICE; NEOPLASTIC STEM CELLS; NODAL PROTEIN; PEPTIDES; PHENOTYPE; PROGNOSIS; SIGNAL TRANSDUCTION; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84899738233     PISSN: 00937754     EISSN: 15328708     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2014.02.001     Document Type: Article

References (35)

1. T. Schatton, and M.H. Frank Cancer stem cells and human malignant melanoma Pigment Cell Melanoma Res 21 2007 39 55
2. Thakur MD, Stuart DD. The evolution of melanoma resistance reveals therapeutic opportunities. Epub 2013 October 4, 10.1158/0008-5472.CAN-13-1633. Available from: www.cancerres.aacrjournlals.org
3. S.A. Williams, W.C. Anderson, M.T. Santaguida, and S.J. Dylla Patient-derived xenografts, the cancer stem cell paradigm, and cancer pathobiology in the 21st century Lab Invest 93 2013 970 982
4. I. Malanchi, A. Santamarie-Martinez, E. Susanto, H. Peng, H.-A. Lehr, and J.-F. Delaloye et al. Interactions between cancer stem cells and their niche govern metastatic colonization Nature 481 7379 2011 85 99
5. K.S. Hoek, and C.R. Goding Cancer stem cells versus phenotype-switching in melanoma Pigment Cell Res 23 2010 746 759
6. J.M. Topczewska, L.M. Postovit, N.V. Margaryan, A. Sam, A.R. Hess, and W.W. Wheaton et al. Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness Nat Med 12 2006 925 932
7. N. Takebe, and S.P. Ivy Controversies in cancer stem cells: targeting embryonic signaling pathways Clin Cancer Res 16 12 2010 3106 3112
8. L.M. Postovit, N.V. Margaryan, E. Seftor, and M.J.C. Hendrix Role of Nodal signaling and the microenvironment underlying melanoma plasticity Pigment Cell Melanoma Res 21 2008 348 357
9. L. Strizzi, L.M. Postovit, N.V. Margaryan, A. Lipavsky, J. Gadiot, and C. Blank et al. Nodal as a biomarker for melanoma progression and a new therapeutic target for clinical intervention Expert Rev Dermatol 4 2009 67 78
10. L. Strizzi, K.M. Hardy, G.T. Kirsammer, P. Gerami, and M.J.C. Hendrix Embryonic signaling in melanoma: potential for diagnosis and therapy Lab Invest 91 2011 819 824
11. A.F. Schier, and M.M. Shen Nodal signalling in vertebrate development Nature 403 2000 385 389
12. K.M. Hardy, D.A. Kirschmann, E.A. Seftor, N.V. Margaryan, L.M. Postovit, and L. Strizzi et al. Regulation of the embryonic morphogen Nodal by Notch4 facilitates manifestation of the aggressive melanoma phenotype Cancer Res 70 2010 10340 10350
13. D.F. Quail, M.J. Taylor, L.A. Walsh, D. Dieters-Castator, P. Das, and M. Jewer et al. Low oxygen levels induce the expression of the embryonic morphogen Nodal Mol Biol Cell 22 24 2011 4809 4821
14. L. Yu, P.W. Harms, P. Pouryazdanparast, D.S. Kim, L. Ma, and D.R. Fullen Expression of the embryonic morphogen Nodal in cutaneous melanocytic lesions Mod Pathol 23 2010 1209 1214
15. C.C. Lee, H.J. Jan, J.H. Lai, H.I. Ma, Hueng Dy, and Y.C. Lee et al. Nodal promotes growth and invasion inhuman gliomas Oncogene 29 2010 3110 3123
16. L. Strizzi, K.M. Hardy, N.V. Margaryan, D.W. Hillman, E.A. Seftor, and B. Chen et al. Potential for the embryonic morphogen Nodal as a prognostic and predictive biomarker in breast cancer Breast Cancer Res 14 R75 2012 1 12
17. M.G. Lawrence, N.V. Margaryan, D. Loessner, A. Collins, K.M. Kerr, and M. Turner et al. Reactivation of embryonic Nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells Prostate 2011 71 1198-209
18. I. Papageorgiou, P.K. Nicholis, F. Wang, M. Lackmann, Y. Makanji, and L.A. Salamonsen et al. Expression of Nodal signaling components in cycling human endometrium and in endometrial cancer Reprod Biol Endocrinol 7 2009 122 133
19. C. Sun, L. Sun, K. Jiang, D.-M. Gao, X.-N. Kang, and C. Wang et al. NANOG promotes liver cancer cell invasion by inducing epithelial-mesenchymal transition through NODAL/SMAD3 signaling pathway Int J Biochem Cell Biol 45 2013 1099 1108
20. E. Lonardo, P.C. Hermann, M.T. Mueller, S. Huber, A. Balic, and I. Miranda-Lorenzo et al. Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy Cell Stem Cell 9 5 2011 433 446
21. L. Strizzi, K.M. Hardy, D.A. Kirschmann, L. Ahrlund-Richter, and M.J.C. Hendrix Nodal expression and detection in cancer: experience and challenges Cancer Res 72 8 2012 1915 1920
22. P. Muller, K.W. Rogers, B.M. Jordan, J.S. Lee, D. Robson, and S. Ramanathan et al. Differential diffusivity of Nodal and Lefty underlies a reaction-diffusion patterning system Science 336 6082 2012 721 724
23. A.E. Prigodich, P.S. Randeria, W.E. Briley, N.J. Kim, W.L. Daniel, and D.A. Golhohann et al. Multiplexed Nanoflares: mRNA detection in live cells Analyt Chem 84 2012 2062 2066
24. Simultaneous detection of a surface protein and its mRNA in living cells by conventional and imaging flow cytometry. EMD Millipore Application Note. 2013. Available from: www.emdmillipore.com/SmartFlare
25. L.-M. Postovit, N.V. Margaryan, E.A. Seftor, D.A. Kirschmann, A. Lipavsky, and W.W. Wheaton et al. Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells Proc Natl Acad Sci U S A 105 11 2008 4329 4334
26. M.J.C. Hendrix, E.A. Seftor, A.R. Hess, and R.E.B. Seftor Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma Nat Rev Cancer 3 2003 411 421
27. M.J.C. Hendrix, R.E.B. Seftor, E.A. Seftor, L.M. Gruman, L.M.L. Lee, and B.J. Nickoloff et al. Transendothelial function of human metastatic melanoma cells: role of the microenvironment in cell-fate determination Cancer Res 62 2002 665 668
28. M.J.C. Hendrix, E.A. Seftor, P.S. Meltzer, L.M.G. Gardner, A.R. Hess, and D.A. Kirschmann et al. Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry Proc Natl Acad Sci U S A 98 14 2001 8018 8023
29. Z.N. Demou, and M.J.C. Hendrix Microgenomics profile the endogenous angiogenic phenotype in subpopulations of aggressive melanoma J Cell Biochem 105 2008 562 573
30. Z.A. Rasheed, J. Kowalski, B.D. Smith, and W. Matsui Concise review: emerging concepts in clinical targeting of cancer stem cells Stem Cells 29 6 2011 883 887
31. E. Quintana, M. Shackleton, H.R. Foster, D.R. Fullen, M.S. Sabel, and T.M. Johnson et al. Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized Cancer Cell 18 2010 8510 8523
32. M.J.C. Hendrix, E.A. Seftor, R.E.B. Seftor, J. Kasemeier-Kulesa, P.M. Kulesa, and L.-M. Postovit Reprogramming metastatic tumour cells with embryonic microenvironments Nat Rev Cancer 7 2007 246 255
33. F.F. Costa, E.A. Seftor, J.M. Bischof, D.A. Kirschmann, L. Strizzi, and K. Arndt et al. Epigenetically reprogramming metastatic tumor cells with an embryonic microenvironment Epigenomics 1 2 2009 387 398
34. G. Rappa, O. Fodstad, and A. Lorico The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma Stem Cells 26 2008 3008 3017
35. + melanoma subpopulations contribute to perivascular niche morphogenesis and tumorigenicity through vasculogenic mimicry Cancer Res 72 19 2012 5111 5118